Wednesday, April 26, 2017

Breaking #Defense Stock News: Patriot One (TSX.V: $PAT) (OTCQB: $PTOTF) Explores Strategic Relationship with Tier 1 Integrator

Breaking #Defense Stock News: Patriot One (TSX.V:  $PAT) (OTCQB:  $PTOTF) Explores Strategic Relationship with Tier 1 Integrator

(TSX.V:  $PAT) (OTCQB:  $PTOTF) advances concealed weapons detection opportunity with global partner



 
TORONTO, ON  April 26, 2017) – Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of a revolutionary award-winning concealed weapons detection system, is pleased to announce its entry into an agreement with a strategic industry partner aimed at significantly broadening its ongoing product commercialization activities.

The opportunity is being undertaken with a well-established and industry leading organization recognized as a Tier 1 Systems Integrator with offices and facilities around the globe. Patriot One has entered into an agreement which provides for a technical evaluation by both parties to identify operational efficiencies and opportunities employing Patriot One’s concealed weapons detection software and related hardware components. This will be accomplished through a series of integration tests with the partner.

Both parties have indicated a willingness in principle to enter into a Value-Added Reseller (VAR) relationship whereby Patriot One may appoint the partner as a sales representative for several potential major markets. The terms and conditions of such a commercial relationship are planned for discussion throughout the evaluation period.  

Company CEO Martin Cronin notes, “Working with major commercial partners exactly aligns with our business model, as it offers extraordinarily attractive opportunities to propel our product roll-out and holds the potential to drive significant awareness of our product’s ability to decrease the menace of random public violence. We are benefitting from a period of intensifying interest and have greatly appreciated inquiries from a number of leading integrators, major potential distributors and resellers from literally around the globe. We attribute much of this interest to our recent and highly successful award-winning debut at ISC West in Las Vegas. It’s an exciting time at Patriot One and we thank everyone for their ongoing commitment and interest in our endeavour.”

ON BEHALF OF THE BOARD

“Martin Cronin"
President & Director


About Patriot One Technologies, Inc. (TSX.V:PAT) (OTCQB: PTOTF) (FRA: 0PL):
Patriot One has developed PATSCAN™ the next generation of its award-winning Patriot One Technologies™ NForce CMR1000 software and radar solution. PATSCAN™ is a first-of-its-kind Cognitive Microwave Radar concealed weapons detection system as an effective tool to combat active shooter threats before they occur. Designed for cost-effective deployment in weapon-restricted buildings and facilities, the Patriot One software solution and related hardware can be installed in hallways and doorways to covertly identify weapons and to alert security of an active threat entering the premises. Owner/operators of private and certain public facilities can now prominently post anti-weapons policies with compliance assured. The Company’s motto Deter, Detect and Defend is based on the belief that widespread use of its technology will act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the globe. For more information, visit: www.patriot1tech.com.
Patriot One Technologies are proud winners of the 2017 Anti-Terrorism / Force Protection category of the Security Industry Association’s New Product Showcase at ISC West
For further information, please contact:
Patriot One Inquiries
+1 (888) 728-1832

CAUTIONARY DISCLAIMER STATEMENT:
No Securities Exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release. This news release contains forward-looking statements relating to product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the relevant securities exchange(s) and other risks detailed from time to time in the filings made by the Company with securities regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news is published on the Investorideas.com Newswire – News that Inspires big ideas

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure this news is a paid for news release on the Investorideas.com newswire by Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF)  Learn more about costs and our newswire service http://www.investorideas.com/News-Upload/


Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


HomelandDefenseStocks.com - investing ideas for Defense stocks, Biometrics stocks, Homeland security stocks, Biodefense stocks, Cyber security stocks

Like Defense and Security Stocks? View our Defense and Security Stocks Directory  Get News Alerts on Defense Stocks



Aesthetic Medical Market News; RepliCel (OTCQB: $REPCF) (TSXV: $RP) Reports US Patent Issued for Novel Dermal Injection Technologies

Aesthetic Medical Market News; RepliCel (OTCQB: $REPCF) (TSXV: $RP) Reports US Patent Issued for Novel Dermal Injection Technologies



"We are confident RepliCel's extensive patent estate for its cell therapy and injection devices will provide our products with long-term market exclusivity," -Lee R. Buckler, CEO


VANCOUVER, BC - April 26, 2017 (Investorideas.com Newswire) Aesthetic Medical Market News alert ; RepliCel Life Sciences Inc. (OTCQB:REPCF) (TSXV:RP) (FRA:P6P2) ("RepliCel" or the "Company"), a clinical stage regenerative medicine company developing cell therapies for aesthetic and orthopedic conditions, today announced the granting of a key patent in the United States (U.S. Patent No. 9,616,182) covering significant components of the Company's novel, multi-needle dermal injection device.



Tuesday, April 25, 2017

Four Stocks Competing in the Medical Aesthetic Market; (NYSE: $AGN), (OTCQB: $REPCF) (TSXV: $RP), (NASDAQ: $HOLX), (ZLTQ)

Four Stocks Competing in the Medical Aesthetic Market; (NYSE: $AGN), (OTCQB: $REPCF) (TSXV: $RP), (NASDAQ: $HOLX), (ZLTQ)



Point Roberts, WA, -April 25, 2017 – Investorideas.com, a global news source covering biotech and medical technology, issues a sector close–up on publicly traded companies competing in the rapidly growing medical aesthetic market.

Company news from Allergan (NYSE: AGN), RepliCel (OTCQB:REPCF) (TSXV:RP), Hologic (NASDAQ: HOLX) and ZELTIQ Aesthetics, Inc. (NASDAQ:  $ZLTQ) showcases recent developments in the sector.


Breaking RepliCel (OTCQB: $REPCF; TSX: $RP.V) @RepliCel News; US Patent Issued to for its Novel Dermal Injection Technologies

Breaking RepliCel (OTCQB: $REPCF; TSX: $RP.V) @RepliCel News; US Patent Issued to for its Novel Dermal Injection Technologies

With exclusive U.S. rights to RCI-02 patents, RepliCel edges its nearest-term commercial asset closer to launch in large aesthetic market



VANCOUVER, BC – April 25, 2017 - (Investorideas.com Newswire) RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV:RP) (FRA:P6P2) (“RepliCel” or the “Company”), a clinical stage regenerative medicine company developing cell therapies for aesthetic and orthopedic conditions, today announced the granting of a key patent in the United States (U.S. Patent No. 9,616,182) covering significant components of the Company’s novel, multi-needle dermal injection device. 



Read this release in full at http://www.investorideas.com/news/2017/biotech/04251REPCF.asp

Investor Ideas Podcast Corner; Insight from the CEO of Publicly Traded Jewelry Company (OTCQB: $RGNP)

Investor Ideas Podcast Corner; Insight from the CEO of Publicly Traded Jewelry Company (OTCQB: $RGNP)



BEVERLY HILLS, CA- April 25 , 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors including luxury brand stocks and luxury brand jewelry companies, releases a new podcast interview featuring Joseph (Yossi) Segelman, CEO, President, Director of  Reign Corporation (OTCQB: RGNP).   



To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Read this release in full at http://www.investorideas.com/CO/RGNP/news/2017/04251Podcast.asp

Gopher Protocol Inc. (OTCQB: $GOPH) Releases GuardianFleet App for optimizing and tracking Business Assets - Add-on to GuardianPack Available on IOS and Android Application for Tracking Business Assets

Gopher Protocol Inc. (OTCQB: $GOPH) Releases GuardianFleet App for optimizing and tracking Business Assets - Add-on to GuardianPack Available on IOS and Android Application for Tracking Business Assets



SAN DIEGO, CA--(Marketwired - April 25, 2017) - Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" and the "Company"), a development-stage company which specializes in the development of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies, and its partner, Guardian Patch LLC ("Guardian"), released a beta version of -- "GuardianFleet" -- tracking application for groups, available on both IOS and Android platforms.




Monday, April 24, 2017

Reign Sapphire Corporation (OTCQB: $RGNP) to Present at the Planet MicroCap Showcase 2017

Reign Sapphire Corporation (OTCQB: $RGNP) to Present at the Planet MicroCap Showcase 2017



NEW YORK, NY - April 24, 2017 (Investorideas.com Newswire) Reign Sapphire Corporation, (OTCQB: RGNP) ("Reign" or the "Company"), a direct-to-consumer, branded and custom jewelry company today announced today that it will be presenting at the inaugural Planet MicroCap Showcase being held on April 26-28, 2017 at the Planet Hollywood Resort & Casino in Las Vegas, NV. The company will be presenting at 3 PM PDT on April 7, 2017.

Joseph Segelman (CEO of Reign Sapphire Corporation) will be presenting, as well as meeting with investors.

Management will also be available for one-on-one meetings at the conference. To schedule a time, contact Robert Kraft, Editor-in-Chief, StockNewsNow.com, the conference organizer, at 424-227-9018 or rkraft@snnwire.com. Visit www.PlanetMicroCapShowcase.com for more information.


About Reign Corporation:
Reign Sapphire Corporation (RGNP) is a Beverly Hills-based, D2C branded and custom jewelry company with 3 niche brands: Reign Sapphire: ethically produced, millennial targeted sapphire jewelry, Coordinates Collection: custom jewelry, inscribed with location coordinates commemorating life's special moments, and Le Bloc jewelry: classic customized jewelry. http://www.reignsc.com.

About the Planet MicroCap Showcase:
The Planet MicroCap Showcase brings together the most promising companies and the top dealmakers in MicroCap Finance for three days of company presentations, one-on-one meetings, and networking in the nation's #1 destination for meetings and entertainment.
Meet C level executives, investors, financial professionals and industry leaders in the MicroCap stock market for an unequaled experience in networking and dealmaking.
For more information about the Planet MicroCap Showcase, please visit: www.PlanetMicroCapShowcase.com.

Forward Looking Statements:
This press release includes "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Reign Sapphire Corporation ("Reign" or the "Company"). Forward-looking statements are based on the expectations, estimates, or projections of the Company's management as of the date of this press release. Although Reign's management believes these expectations, estimates, or projections to be reasonable as of the date of this presentation, forward-looking statements are inherently subject to significant business risks, economic and competitive uncertainties, or other contingencies, which could cause the Company's actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause Reign's actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" sections in the Company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2015, which is available for viewing on the SEC's EDGAR website. These forward-looking statements speak only as of the date of this press release and, except as required by law, Reign specifically disclaims any obligation to update these forward-looking statements, even if new information becomes available in the future.

Investor and Media Inquiries:
info@reignsc.com
+1 (213) 457-3772

SOURCE: Reign Sapphire Corp.

More info on RGNP at Investorideas.com Visit: http://www.investorideas.com/CO/RGNP/

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Sign up for free news alerts

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp, Disclosure : RGNP is a paid news publishing, social media and PR client on Investorideas.com / renewal March 22, 2017 one thousand per month and equivalent of $2000 per month in restricted shares.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Friday, April 21, 2017

GPS, Tech & Biotech Stocks Added to Investorideas.com


GPS, Tech & Biotech Stocks Added to Investorideas.com

New Tech Stocks Added to Directory - $DGST, $MLJB and $KPAY



Point Roberts, WA, Delta BC – April 21, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its investor membership, including global stock directories in GPS, technology and biotech.

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listing for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

The newest GPS stocks include DSG Global Inc. (OTC:DSGT) a provider of patented electronic tracking systems and fleet management solutions to golf courses that is now expanding into Commercial Fleet Management, and Agricultural applications and Ultrack Systems Inc. (OTC:MJLB), a GPS tracking solution provider for service driven industries.

Also new this week in tech is the Indonesian-based, digital payment company KinerjaPay Corp (OTC: KPAY), who enable consumers to "Pay, Play and Buy" through secure web portal and mobile applications.

The latest additions in biotech include a specialty biotechnology company that has a proprietary transdermal delivery system platform used to deliver pharmaceutical and natural molecules in a targeted specific manner (this company has also recently crossed over into the medical marijuana field) and Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), a stem cell biotech company developing proprietary cell therapies for the treatment of cancer and degenerative diseases.
   
New Technology Companies Added to Investorideas directory:
DSG Global Inc. (OTC:DSGT) provides patented electronic tracking systems and fleet management solutions to golf courses that allow for remote management of the course's fleet of golf carts, turf equipment and utility vehicles. Their clients use DSGT's unique technology to significantly reduce operational costs, increase safety, and enhance customer satisfaction. DSGT has grown to become a leader in the category of Fleet Management in the golf industry, with their technology installed in over 15,000 vehicles on more than 250 courses worldwide. DSGT is now aggressively branching into several new streams of revenue, through programmatic advertising, licensing and distribution. DSGT is also expanding into Commercial Fleet Management, and Agricultural applications.

Ultrack Systems Inc. (OTC:MJLB) is a provider of GPS tracking solutions. We develop, implement and distribute electronic monitoring and tracking systems for companies in leasing, transportation, construction, disposal and many other service driven industries. Our platform includes live tracking, reports and alerts on a web-based platform. Our mission is to provide the best fleet tracking, reporting systems and our commitment to service.

KinerjaPay Corp ( OTC: KPAY) enables consumers to "Pay, Play and Buy" through its secure web portal and mobile applications. Based in Indonesia, the Company provides easy and convenient payment solution while shopping online at its marketplace platform. With its current omni-channel platform, users can perform various payment services such as credit card bill payment, utility, phone bill, healthcare insurance and direct transfer to anyone at their convenience. KinerjaPay is also planning to launch other eCommerce verticals such as travel market, delivery services, and online gaming in the near future

New Biotech Companies Added:
Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards.  CBMG recently commenced two Phase I human clinical trials in China using CAR-T to treat relapsed/refractory CD19+ B-cell Acute Lymphoblastic Leukemia (ALL) and Refractory Diffuse Large B-cell Lymphoma (DLBCL) as well as an ongoing Phase I trial in China for AlloJoinTM (CBMG`s "Off-the-Shelf" Allogeneic Human Adipose-derived Mesenchymal Stem Cell) for the treatment of Knee Osteoarthritis (KOA). CBMG was also recently awarded $2.29 million from the California Institute for Regenerative Medicine (CIRM) to support pre-clinical studies of AlloJoinTM for Knee Osteoarthritis in the United States.

Delivra Corp. (TSX:DVA.V) is a specialty biotechnology company that has a proprietary transdermal delivery system platform that can shuttle pharmaceutical and natural molecules, through the skin, in a targeted specific manner. Delivra manufactures and sells a growing line of natural topical creams with the proprietary transdermal delivery system platform under the LivRelief™ brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and under the LivSport™ brand for sports performance. LivRelief™ products are available in pharmacies, grocery chains, and independent health food stores across Canada, and on-line at www.livrelief.com. LivRelief™ pain and nerve pain products are also available in the United States on Amazon and at www.livrelief.com/us. In parallel with its consumer products business, Delivra also has a mandate to license its patent-pending proprietary transdermal delivery technology platform to pharmaceutical companies globally, for the repurposing of pharmaceutical molecules transdermally to treat a broad range of conditions, along with licensing its over-the-counter products globally. Delivra is headquartered in Burlington, Ontario and has a research and development laboratory in Charlottetown, PEI.


Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Investorideas.com CSE service provider directory listing: http://thecse.com/en/services/services-for-listed-companies


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411















This Week’s Cannabis and Hemp Stocks Added; $DVA.V; $SVSN

This Week’s Cannabis and Hemp Stocks Added; $DVA.V; $SVSN

Other New Marijuana/Hemp Stocks: ASX: ZLD, BOT, CPH, MDC



Point Roberts, WA, Delta BC – April 21, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its cannabis /hemp stock directory for investors following the sector.

Australian listed (ASX) stocks are at the forefront of this week’s additions with 4 new stocks being added that include a company involved in medical cannabis for treatment of a variety of ailments; a cannabis-based medicine for oncology; cannabidiol treatment for psoriasis and atopic dermatitis and Creso Pharma Limited (ASX:CPH.AX) a leader in cannabidiol (CBD) innovation, currently developing cannabis and hempderived therapeuticgrade Nutraceuticals and Medical Cannabis products with a broad range of applications in both human and animal health.

Also new this week are Delivra Corp. (TSX:DVA.V) is a specialty biotechnology company who recently completed a strategic partnership with Dosecann Inc. and ARA-Avanti RX Analytics Inc. to develop a unique suite of standardized and commercialized products for the medical cannabis market and Stereo Vision Entertainment, Inc. (OTC:SVSN) a media company who is also the majority owner of medical cannabis and organic hemp subsidiary, MediCannaVision Inc., dba CannaVision.

Investorideas.com cannabis/marijuana and hemp content now includes: http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com





New Marijuana Companies Added to the Investor cannabis stock directory:

Botanix Pharmaceuticals Ltd. (ASX:BOT.AX) mission is to improve the lives of patients battling acne, psoriasis and atopic dermatitis, by providing new treatment options for conditions that currently are inadequately addressed or are treated with therapeutics that are burdened with side effects profiles. We are harnessing the untapped potential of a synthetic active pharmaceutical ingredient known as cannabidiol which is currently being studied for the treatment of epilepsy, pain, arthritis and schizophrenia amongst other indications. Botanix is preparing for the first human trials utilizing synthetic cannabidiol in a proprietary drug delivery system (Permetrex™) for direct skin delivery of the therapy.

Creso Pharma Limited (ASX:CPH.AX) pharmaceutical expertise and methodological rigour to the world of medical cannabis and strives for the highest quality in its products, leveraging science and research in order to develop, register and commercialise innovative therapeutic approaches targeting the endocannabinoid system. Creso Pharma is a leader in cannabidiol (CBD) innovation, developing cannabis- and hempderived therapeuticgrade Nutraceuticals and Medical Cannabis products with a broad range of applications in both human and animal health. Creso Pharma’s innovative CBD fully plant-based nutraceutical products are non-psychoactive, as they contain only trace amounts of THC. Focusing on unique and innovative product delivery systems, Creso Pharma is developing therapeutic products and nutraceuticals manufactured according to the highest GMP standards, and maintaining the highest levels of compliance across the supply chain. Creso Pharma holds worldwide rights for a number of proprietary innovative delivery technologies which enhance the bioavailability and absorption of cannabinoids. Furthermore, Creso Pharma’s standardised dosage forms are specifically designed and adapted for human health and for animal health, and for several medical conditions including pain and anxiety disorders, metabolic disorders and inflammatory disorders.

Delivra Corp. (TSX:DVA.V) is a specialty biotechnology company that has a proprietary transdermal delivery system platform that can shuttle pharmaceutical and natural molecules, through the skin, in a targeted specific manner. Delivra manufactures and sells a growing line of natural topical creams with the proprietary transdermal delivery system platform under the LivRelief™ brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and under the LivSport™ brand for sports performance. LivRelief™ products are available in pharmacies, grocery chains, and independent health food stores across Canada, and on-line at www.livrelief.com. LivRelief™ pain and nerve pain products are also available in the United States on Amazon and at www.livrelief.com/us. In parallel with its consumer products business, Delivra also has a mandate to license its patent-pending proprietary transdermal delivery technology platform to pharmaceutical companies globally, for the repurposing of pharmaceutical molecules transdermally to treat a broad range of conditions, along with licensing its over-the-counter products globally. Delivra is headquartered in Burlington, Ontario and has a research and development laboratory in Charlottetown, PEI. Cannabis: Completed a strategic partnership with Dosecann Inc. and ARA-Avanti RX Analytics Inc. to develop a unique suite of standardized and commercialized products for the medical cannabis market

Medlab Clinical Ltd. (ASX:MDC.AX) l is an Australian based medical life science company, with a certified biologics facility in Sydney and sales arms in Australia and California. Medlab’s research relates to five health areas - obesity, chronic kidney disease, depression, ageing and muscular skeletal health and pain management. A lot of Medlab’s research is on the role bacteria in the gastrointestinal tract play in health and disease, leading to drug discovery and development of new medicines involving bacteria (pharmacobiotics) as well as nutritional products. Medlab is also about to commence a human trial of a cannabis-based medicine for oncology patients with intractable pain, utilising its small particle medicine delivery system, Nanocelle™. Medlab has a growing patent portfolio, multiple published research papers and conference presentations and the Pharmacobiotic trademark – a therapeutic term referring to both probiotics and biologics.

Stereo Vision Entertainment, Inc. (OTC:SVSN) is a publicly traded Nevada company focused on creating, acquiring, and producing multimedia content with its media subsidiaries the majority owned family entertainment company Inspirational Vision Media and the wholly owned 9 time Emmy Award winning production company REZN8, and the majority owned medical cannabis and organic hemp subsidiary, MediCannaVision Inc., dba CannaVision.

Zelda Therapeutics Limited (ASX:ZLD.AX) has been formed to bring together some of the world’s leading researchers and clinicians active in the study and use of medicinal cannabis to treat a variety of ailments.

The complete marijuana/hemp stock list available for purchase in a PDF format:

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listing for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Services for Publicly traded and private companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411


Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news